290 related articles for article (PubMed ID: 32101030)
1. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
2. RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice.
Duggan BM; Cavallari JF; Foley KP; Barra NG; Schertzer JD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32473019
[TBL] [Abstract][Full Text] [Related]
3. NOD1 activators link innate immunity to insulin resistance.
Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.
Duggan BM; Foley KP; Henriksbo BD; Cavallari JF; Tamrakar AK; Schertzer JD
Sci Rep; 2017 May; 7(1):1578. PubMed ID: 28484277
[TBL] [Abstract][Full Text] [Related]
5. Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.
Zhou YJ; Liu C; Li CL; Song YL; Tang YS; Zhou H; Li A; Li Y; Weng Y; Zheng FP
Obesity (Silver Spring); 2015 Jul; 23(7):1394-400. PubMed ID: 26052894
[TBL] [Abstract][Full Text] [Related]
6. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
[TBL] [Abstract][Full Text] [Related]
7. Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch,
Peng XY; Wang KL; Li L; Li B; Wu XY; Zhang ZW; Li N; Liu LH; Nie P; Chen SN
Front Immunol; 2024; 15():1374368. PubMed ID: 38715616
[TBL] [Abstract][Full Text] [Related]
8. Postbiotics engage IRF4 in adipocytes to promote sex-dependent changes in blood glucose during obesity.
Duggan BM; Singh AM; Chan DY; Schertzer JD
Physiol Rep; 2022 Aug; 10(16):e15439. PubMed ID: 35993451
[TBL] [Abstract][Full Text] [Related]
9. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes.
Steinle H; Ellwanger K; Mirza N; Briese S; Kienes I; Pfannstiel J; Kufer TA
J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34152391
[TBL] [Abstract][Full Text] [Related]
12. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.
Vieira SM; Cunha TM; França RF; Pinto LG; Talbot J; Turato WM; Lemos HP; Lima JB; Verri WA; Almeida SC; Ferreira SH; Louzada-Junior P; Zamboni DS; Cunha FQ
J Immunol; 2012 May; 188(10):5116-22. PubMed ID: 22491249
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes.
Rodrigues E-Lacerda R; Fang H; Robin N; Bhatwa A; Marko DM; Schertzer JD
Biomed J; 2023 Oct; 46(5):100610. PubMed ID: 37263539
[TBL] [Abstract][Full Text] [Related]
14. RIPK2 NODs to XIAP and IBD.
Topal Y; Gyrd-Hansen M
Semin Cell Dev Biol; 2021 Jan; 109():144-150. PubMed ID: 32631784
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
17. Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
Fan YH; Roy S; Mukhopadhyay R; Kapoor A; Duggal P; Wojcik GL; Pass RF; Arav-Boger R
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7818-E7827. PubMed ID: 27856764
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2.
Ver Heul AM; Fowler CA; Ramaswamy S; Piper RC
J Biol Chem; 2013 Mar; 288(10):6890-902. PubMed ID: 23300079
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
Damgaard RB; Nachbur U; Yabal M; Wong WW; Fiil BK; Kastirr M; Rieser E; Rickard JA; Bankovacki A; Peschel C; Ruland J; Bekker-Jensen S; Mailand N; Kaufmann T; Strasser A; Walczak H; Silke J; Jost PJ; Gyrd-Hansen M
Mol Cell; 2012 Jun; 46(6):746-58. PubMed ID: 22607974
[TBL] [Abstract][Full Text] [Related]
20. Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4.
Cavallari JF; Fullerton MD; Duggan BM; Foley KP; Denou E; Smith BK; Desjardins EM; Henriksbo BD; Kim KJ; Tuinema BR; Stearns JC; Prescott D; Rosenstiel P; Coombes BK; Steinberg GR; Schertzer JD
Cell Metab; 2017 May; 25(5):1063-1074.e3. PubMed ID: 28434881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
